CircaGene
London-based CircaGene operates a personal genetic testing platform for preventive healthcare, using patented Fully Homomorphic Encryption to deliver privacy-preserving actionable results to consumers; founded 2018 with minimal disclosed capital and a small team.
- Company typePrivate
- Founded2018
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2C
- OfferingServices
What CircaGene does
CircaGene is a London-based, privately-held for-profit company founded in 2018 that operates a personal genetic testing platform targeting consumers in the preventive healthcare segment. The company's stated differentiator is a "Privacy-Patented" application of Fully Homomorphic Encryption (FHE) — a cryptographic technique that theoretically allows computation on encrypted genetic data without exposing the underlying plaintext — intended to deliver actionable health insights while preserving user privacy.
The company is very small, with reported headcount of 1-10 employees and a leadership team consisting of CEO François Paillier and COO/CXO Jackeline Palma. To date, only one funding round has been disclosed: approximately $230,025 closed in April 2020 from Loyal VC and SFC Capital. The consumer-facing website (circagene.com) is presently displaying a maintenance page hosted by accessly.io with IOSBET branding, indicating the storefront is not actively serving customers. No pricing, product SKUs, customer logos, distribution channels, certifications, or revenue figures are disclosed in the available source material, and the company's operating status and commercial continuity are not clearly determinable from public data.
Functionally, the proposition combines direct-to-consumer genetic testing with health interpretation services rendered inside an encrypted-compute envelope. Specifics of the testing methodology (e.g., genotyping vs. sequencing), the variant interpretation pipeline, the regulatory pathway (e.g., IVD, LDT, wellness), and the go-to-market mechanics (D2C kit sales, B2B partnerships, telehealth integration) are not stated in the source data and cannot be reliably inferred.
CircaGene firmographics
Firmographics- Name
- CircaGene
- Website
- https://circagene.com
- Company type
- Private
- Founded year
- 2018
- Headcount range
- 1–10 employees
- Short description
- London-based CircaGene operates a personal genetic testing platform for preventive healthcare, using patented Fully Homomorphic Encryption to deliver privacy-preserving actionable results to consumers; founded 2018 with minimal disclosed capital and a small team.
- Ownership category
- akta.pro rank
CircaGene industry classification
Industry- Product category
- Personal Genomics / Genetic Testing Services
- NAICS
- Testing Laboratories and Services (541380)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)
- akta.pro secondary industry
- Population Genomics & Preventive Precision Health Programs (HLAAANAL)
Keywords
Where CircaGene is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
CircaGene business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
CircaGene product offering
Product offeringCore offering
CircaGene provides personal genetic tests for individual consumers, returning actionable preventive-healthcare results while keeping DNA data protected through its patented Fully Homomorphic Encryption (FHE) platform. The service combines a consumer-facing DNA test with privacy-preserving computation so that genetic information is not exposed in plaintext during analysis.
Differentiator
Problem solved
Functional benefit
Products and services
- Personal Genetic Test A consumer-facing DNA test that returns actionable preventive-healthcare results to individual users, processed through CircaGene's patented Fully Homomorphic Encryption (FHE) platform so that genetic data is not exposed in plaintext during analysis. Targeted at privacy-conscious individual consumers.
Companies that use CircaGene
Customer profileIdeal customer profiles1 record
CircaGene technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CircaGene partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights1 record
CircaGene competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific: Major life sciences tools and diagnostics provider offering genetic testing instruments, reagents, and services. Comparable as an established player in the broader genetic testing infrastructure space.
- Illumina: Dominant DNA sequencing technology and platform provider serving the entire genomics ecosystem, including consumer testing companies. Comparable as an enabling incumbent that shapes the economics of personal genetic testing.
Direct peers
- MyHeritage DNA: Consumer genetic testing service offered alongside family-tree software, with significant presence in Europe. Comparable personal genetic testing offering to CircaGene, particularly relevant given CircaGene's London base.
- Dante Labs: European-based personal whole-genome sequencing provider offering DTC genetic tests with health and ancestry insights. Comparable given overlapping European market focus and personal genomics product.
- 23andMe: Leading consumer genetic testing company offering personal DNA tests for ancestry, health, and wellness. Direct competitor to CircaGene in the personal genetic testing space, though 23andMe does not offer FHE-level encryption.
- Nebula Genomics: Personal genomics company that has explicitly emphasized privacy and encrypted data handling as a differentiator. Closest conceptual peer to CircaGene given shared focus on privacy-preserving genetic testing.
- Color Genomics: Genetic testing company focused on health risk and preventive insights rather than ancestry, with employer and clinical channels. Directly comparable given CircaGene's preventive healthcare positioning.
- Ancestry (AncestryDNA): Major consumer genetic testing provider focused on ancestry and family history, with a large proprietary DNA database. Directly comparable as a personal genetic test platform competing for the same consumer audience.
Emerging players
- EncrypGen: Blockchain-based genomic data marketplace focused on letting users control and monetize their genetic data. Conceptually adjacent to CircaGene in emphasizing privacy and user sovereignty over genetic information.
- Genomics plc: UK-based genomics company applying population-level genetic data to predict disease risk and partner with pharma. Comparable in preventive health genomics orientation and UK domicile, though more enterprise-focused than CircaGene's consumer angle.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
CircaGene social profiles
Digital presenceCircaGene financial estimates
Financial estimateRevenue estimate
Valuation estimate
CircaGene leadership team
Management profileNumber of profiles
Profiles2 records
CircaGene funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CircaGene M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CircaGene
What does CircaGene do?
CircaGene provides personal genetic tests for individual consumers, returning actionable preventive-healthcare results while keeping DNA data protected through its patented Fully Homomorphic Encryption (FHE) platform. The service combines a consumer-facing DNA test with privacy-preserving computation so that genetic information is not exposed in plaintext during analysis.
When was CircaGene founded?
CircaGene was founded in 2018. It employs 1 to 10 people.
Where is CircaGene based?
CircaGene is headquartered in London, United Kingdom, in the Europe region.
Who are CircaGene's main competitors?
Broad incumbents on record are Thermo Fisher Scientific and Illumina. Direct peers are MyHeritage DNA, Dante Labs, 23andMe, Nebula Genomics, Color Genomics and Ancestry (AncestryDNA). Emerging players are EncrypGen and Genomics plc.
Does CircaGene have an API?
No public API is recorded for CircaGene.
What industry is CircaGene in?
CircaGene's product category is Personal Genomics / Genetic Testing Services. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLAAANAL, Population Genomics & Preventive Precision Health Programs. Its NAICS code is 541380 and its SIC code is 2835.